Private ADHD Assessments Soar As Public Services Struggle In EnglandBy Press Room21 October 2024 Demand for private ADHD assessments is soaring in England as the scale of referrals overwhelms the public health system. The…
How This $4.3B Pharma Company Is Helping Underserved Patients in NeuroBy Press Room7 August 2024 For over 30 years, Richard Pops has been the CEO of Alkermes (NASDAQ: ALKS), a company steadfastly focused on neuroscience—a…